VAN NAARDEN JACOB (Chief Business Officer) sold 42.2% of their position (10K shares) of LOXO ONCOLOGY, INC. on the open market
Open‑market sale worth $1.66M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+5.50K
Price / share
$3.65
Trade value
$20.06K
% of position
Common Stock
Shares
−756.00
Price / share
$164.44
Trade value
$124.32K
% of position
Common Stock
Shares
−1.89K
Price / share
$165.32
Trade value
$311.62K
% of position
Common Stock
Shares
−1.06K
Price / share
$166.74
Trade value
$176.58K
% of position
Common Stock
Shares
−1K
Price / share
$167.39
Trade value
$167.39K
% of position
Common Stock
Shares
−200.00
Price / share
$168.78
Trade value
$33.76K
% of position
Common Stock
Shares
−600.00
Price / share
$171.03
Trade value
$102.62K
% of position
Common Stock
Shares
+4.50K
Price / share
$3.65
Trade value
$16.42K
% of position
Common Stock
Shares
−2.70K
Price / share
$165.45
Trade value
$446.71K
% of position
Common Stock
Shares
−1.50K
Price / share
$166.63
Trade value
$249.95K
% of position
Common Stock
Shares
−300.00
Price / share
$167.49
Trade value
$50.25K
% of position
Net shares
+0.00
Net value
-$1.63M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/12/2018 | M · Option Exercise | +5.50K | $3.65 | $20.06K | 40.1% | 13.70K | 19.20K |
| Common Stock Direct | 9/12/2018 | S · Sale | −756.00 | $164.44 | $124.32K | 3.9% | 19.20K | 18.44K |
| Common Stock Direct | 9/12/2018 | S · Sale | −1.89K | $165.32 | $311.62K | 10.2% | 18.44K | 16.56K |
| Common Stock Direct | 9/12/2018 | S · Sale | −1.06K | $166.74 | $176.58K | 6.4% | 16.56K | 15.50K |
| Common Stock Direct | 9/12/2018 | S · Sale | −1K | $167.39 | $167.39K | 6.5% | 15.50K | 14.50K |
| Common Stock Direct | 9/12/2018 | S · Sale | −200.00 | $168.78 | $33.76K | 1.4% | 14.50K | 14.30K |
| Common Stock Direct | 9/12/2018 | S · Sale | −600.00 | $171.03 | $102.62K | 4.2% | 14.30K | 13.70K |
| Common Stock Direct | 9/13/2018 | M · Option Exercise | +4.50K | $3.65 | $16.42K | 32.8% | 13.70K | 18.20K |
| Common Stock Direct | 9/13/2018 | S · Sale | −2.70K | $165.45 | $446.71K | 14.8% | 18.20K | 15.50K |
| Common Stock Direct | 9/13/2018 | S · Sale | −1.50K | $166.63 | $249.95K | 9.7% | 15.50K | 14K |
| Common Stock Direct | 9/13/2018 | S · Sale | −300.00 | $167.49 | $50.25K | 2.1% | 14K | 13.70K |
| Total | +0.00 | -$1.63M | ||||||
Employee Stock Option (Right to Buy)
Common Stock
5.50K shares
Shares
−5.50K
Strike price
3.648
Held after
62.77K
Exercisable
—
Employee Stock Option (Right to Buy)
Common Stock
4.50K shares
Shares
−4.50K
Strike price
3.648
Held after
58.27K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock5.50K shares | 9/12/2018 | M · Option Exercise | −5.50K | 3.648 | — | 62.77K |
| Employee Stock Option (Right to Buy) Direct | Common Stock4.50K shares | 9/13/2018 | M · Option Exercise | −4.50K | 3.648 | — | 58.27K |